Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Sugi Holdings Co ( (JP:7649) ) has provided an update.
Sugi Holdings reported robust consolidated results for the fiscal year ended February 28, 2026, with net sales surpassing ¥1 trillion, up 15.1% year on year, and profit attributable to owners of parent jumping 75.1%. Operating profit rose 14.1%, margins held steady, and cash flows strengthened significantly, lifting cash and equivalents to over ¥111 billion while net assets expanded and total assets increased.
The company kept its annual dividend at ¥35 per share and forecasts further top-line and profit growth in the year to February 2027, despite projecting a decline in earnings per share due to base effects. It also plans a 2-for-1 stock split and expects to make Seki Yakuhin Co., Ltd. a consolidated subsidiary, signaling continued expansion of its drugstore footprint and potentially greater scale benefits for shareholders and other stakeholders.
The most recent analyst rating on (JP:7649) stock is a Buy with a Yen4219.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.
More about Sugi Holdings Co
Sugi Holdings Co., Ltd. is a Japan-based operator of drugstores and related healthcare retail businesses, listed on the Tokyo and Nagoya stock exchanges under securities code 7649. The group focuses on pharmacy and drugstore operations, selling pharmaceuticals, daily necessities, and health-related products to consumers across its store network in Japan.
Average Trading Volume: 720,564
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen684.5B
For an in-depth examination of 7649 stock, go to TipRanks’ Overview page.